PhRMA SVP Ken Johnson, responding to a Christian Science Monitor piece critical of drug DTC advertising, said the newspaper "unfortunately overlooks the educational benefits of direct-to-consumer advertising of prescription medicines."
PhRMA SVP Ken Johnson, responding to a Christian Science Monitor piece critical of drug DTC advertising, said the newspaper “unfortunately overlooks the educational benefits of direct-to-consumer advertising of prescription medicines.”
From the August 01, 2006 Issue of MM+M - Medical Marketing and Media
Get the most out of 
Register for free and enjoy unlimited access to:
